00:00
00:00
00:00
Polarean Imaging plc - First patient in Phase III FDA Clinical Trial

We speak with Richard Hullihen, CEO of Polarean, following the successful enrolment of the first patient into the Phase III clinical trial which aims to demonstrate non-inferiority of the Company's drug/device combination

Richard Hullihen
CEO

Company Events - POLAREAN IMAGING PLC